SCM
MXCT icon

Sterling Capital Management’s MaxCyte MXCT Stock Holding History

Sterling Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,347
Closed -$2.35K – 3372
2026
Q1 		$2.35K Sell
3,347
-2,481
-43% -$2.32K ﹤0.01% 2959
2025
Q4 		$9.03K Sell
5,828
-1,149
-16% -$1.83K ﹤0.01% 2661
2025
Q3 		$11K Buy
6,977
+4,141
+146% +$7.2K ﹤0.01% 2442
2025
Q2 		$6.18K Buy
2,836
+1,010
+55% +$2.45K ﹤0.01% 2403
2025
Q1 		$4.99K Sell
1,826
-1,526
-46% -$6.02K ﹤0.01% 2166
2024
Q4 		$13.9K Buy
3,352
+2,985
+813% +$11.3K ﹤0.01% 2003
2024
Q3 		$1.43K Buy
+367
New +$1.55K ﹤0.01% 2361

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Sterling Capital Management's MXCT Position: Q2 2026 in Review

Sterling Capital Management sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 3,347 shares — an estimated $2.35K sold.

Sterling Capital Management first reported a position in MXCT in Q3 2024 and held it in 7 quarters. The position peaked at $13.9K in Q4 2024. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Sterling Capital Management reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 3,347 MaxCyte shares in Q2 2026, an estimated $2.35K.
  • Sterling Capital Management first reported a position in MaxCyte in Q3 2024 and held it in 7 quarters.
  • Sterling Capital Management's MaxCyte position peaked at $13.9K in Q4 2024.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.